Back to News
Market Impact: 0.25
Krystal Biotech, Inc. (KRYS) Surpasses Q3 Earnings and Revenue Estimates
Source: zacks.com
Corporate EarningsAnalyst EstimatesHealthcare & Biotech
Krystal Biotech reported quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.84 by $0.21. Earnings were down from $2.66 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment
KRYS0.40
More News
- Stocks making the biggest moves midday: Oracle, SpaceX, Tempus AI, Rivian & more
- Palantir reports booming U.S. commercial revenue growth, topping government for first time
- Anthropic releases amended IPO prospectus with third-quarter financials
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Anthropic to Spend $895 Billion in the Years Ahead
- Oracle Kicks Off $20 Billion Capital Raise